The core of AEGIS is its custom class system, which models the hierarchical nature of genomic annotations. This object-oriented approach provides several key advantages over traditional, line-by-line ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The program pairs FDA-approved ...

Marc Santos is a Guides Staff Writer from the Philippines with a BA in Communication Arts and over six years of experience in writing gaming news and guides. He plays just about everything, from ...

CVS is introducing a major change to the way it packages its over-the-counter drugs as part of its ongoing brand refresh. The pharmacy chain will soon begin to sell its OTC medications in bottles made ...

The launch begins with value-sized CVS brand Allergy and Pain Relief support products. More broadly, this update reflects an ongoing effort at CVS to rethink how everyday healthcare products are ...

CVS is changing up its over-the-counter pill bottles, swapping out the plastic for aluminum. For decades, pills have typically come packaged in hard plastic containers. While technically recyclable, ...

Below, Melissa Reeve shares five key insights from her new book, Hyperadaptive: Rewiring the Enterprise to Become AI-Native. Melissa was the first VP of marketing at Scaled Agile and thought leader in ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. This week was ...

Mass General Brigham and CVS moved closer Thursday to partnering on bringing primary care services to 37 pharmacies across Massachusetts. The Massachusetts Health Policy Commission completed its ...

Nearly a year after CVS Caremark dropped Eli Lilly's blockbuster Zepbound from its standard coverage plan, causing anxiety for thousands of patients and prescribers, the pharmacy benefit manager ...

CVS Health announced it will reinstate coverage of Eli Lilly's blockbuster weight-loss injectable Zepbound and begin coverage of the anti-obesity pill Foundayo for millions of Americans on private ...

More than 10 million US patients will regain easy access to Eli Lilly & Co.’s obesity shot Zepbound through insurance after CVS Health Corp. reversed a controversial decision to restrict it for ...